Medivolve Inc. announced that David Preiner has been appointed Chief Executive Officer (CEO), effective immediately. Preiner will succeed Doug Sommerville, who will assist as a transitionary advisor to the new CEO. As Medivolve's CEO, Preiner will lead a team of computer scientists, engineers, and physicians to build a next-generation, data-driven healthcare system set to transform human health management across the United States. Preiner will serve concurrently as CEO of Xenomics where he leads a PhD-level team focused on advancing breakthroughs in genetics and biomanufacturing to combat global sustainability issues in food, energy, and health. Sommerville is stepping down as Medivolve CEO and a director to pursue personal interests and to focus on his board and advisory roles.